Ivan Poullaos
Partner
Ivan is an accomplished patent trial lawyer with particular experience representing pharmaceutical companies in Hatch-Waxman and biologics infringement cases. Chambers USA recognized Ivan as an “Up and Coming Practitioner” for intellectual property, noting that he “is an extremely responsive and trial-savvy lawyer.”
Key Matters
Achieved a notable trial win for a generic pharmaceutical company by convincing the court to invalidate the patent covering the active ingredient molecule in the Hepatitis B treatment, Baraclude® (entecavir). The decision was especially important because, for the first time, it invalidated as “obvious” a patent on a new chemical compound. The case received extensive press coverage, including articles in Forbes, Bloomberg, Law360, Inside Counsel, and countless IP, FDA, and patent law-related blogs. Ivan also represented this client in the appellate stage of the case, where the district court’s ruling was affirmed.
Achieved a pharmaceutical trial victory in a case in which the court invalidated the patent on the Testim® (testosterone gel) product.
Ivan’s other noteworthy pharmaceutical patent cases have included:
- The anticancer treatments Clolar® (clofarabine), Faslodex® (fulvestrant), Temodar® (temozolomide), and Gilotrif® (afatinib);
- The opioid dependence treatment products Zubsolv®, Suboxone® tablets, and Subutex® tablets (buprenorphine and buprenorphine/naloxone);
- The pain relief products Lidoderm® (lidocaine patch), Exalgo® (hydromorphone HCl), and Abstral® (fentanyl sublingual tablets);
- The IBS (peptide) drug Linzess® (linaclotide);
- The antibiotics Omnicef® (cefdinir), and Dificid® (fidaxomicin);
- The nasal steroid drug Veramyst® (fluticasone furoate);
- The dementia treatment Exelon® (rivastigmine);
- The prostate treatment Avodart® (dutasteride);
- The estrogen modulator Evista® (raloxifene);
- The low testosterone treatments Fortesta® (testosterone gel) and Testim® (testosterone gel); and
- The diabetes and weight loss drugs Tradjenta® (linagliptin), Jentadueto® (linagliptin/metformin), and Qsymia® (phentermine/topiramate).
Ivan’s experience also includes a broad range of commercial, mechanical, and high-tech patent cases. For example, Ivan has represented:
- A worldwide leader in IT and networking in matters involving virtual private network (VPN) tunneling;
- Two leading high-tech companies in cases involving video processing technology and tablet computers;
- A financial technology firm in a patent infringement case involving software for electronic futures trading;
- A telecommunications firm in patent cases involving mobile telecommunications data networks and voice-over-IP systems;
- One of the world's leading technology companies in a suit relating to the development of its first smartphone;
- A defense firm in a patent case involving a “rolling code” security software algorithm;
- A railcar manufacturer in a patent case concerning gondola rail car designs;
- An agribusiness company in a mechanical patent case involving an enclosed belt conveyor; and
- A global automotive parts company in counseling concerning patents on brake rotors and brake pads.
A highly adept litigator who is incredibly effective in developing creative, factually driven legal positions through all phases of a case.
IAM Patent 1000 client testimonial